A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

OrthAlign Reaches Milestone in Orthopedic Surgery at Hospital for Special Surger

OrthAlign, Inc., a pioneering medical device company that provides orthopedic surgeons with advanced precision computer-assisted technology, is celebrating the 16,500th procedure at Hospital for Special Surgery (HSS) with 25 of its surgeons using its technology in hip and knee replacements.

OrthAlign is a handheld navigation device that allows for accurate component positioning for total and partial knee and total hip arthroplasty. The next generation platform weighs only 7 ounces and is designed to improve results through simple workflows.

OrthAlign, Inc., is celebrating the 16,500th procedure at Hospital for Special Surgery (HSS).

It is more efficient and cost effective than previous surgical technologies, as it can be used without the financial investment, pre-operative imaging, or processes required by many robotic or computer-assisted surgical systems.

“This is another great milestone for our organization, says Eric Timko, Chairman and CEO of OrthAlign, Inc. “Technology in every room and in every case is the future; OrthAlign is the catalyst to make that happen.”

OrthAlign consists of one single-use disposable unit and one tray per patient case. This meets the needs of multiple operating rooms, increasing the number of surgeries that can be performed per facility. In addition, it shortens operating room time and reduces the cost to surgeons and patients. It is run on an Android system and is compatible with standard implant systems.

“Using OrthAlign technology allows me to accurately execute my cuts in TKA. The system is simple, and it allows me to have the freedom to adjust my game plan intraoperatively,” says orthopedic surgeon Dr. Cynthia Kahlenberg.

“Without a lot of extra work or planning, I can get all the important information out of the system – perfect alignment and reliability.” says Dr. Mike Ast, an orthopedic surgeon.

Dr. Michael Parks, orthopedic surgeon, says, “using OrthAlign provides me added confidence in the accuracy of the cuts I perform in TKA. This is especially useful in patients with difficult anatomy and in obese patients to ensure satisfactory placement of the knee components.”

Dr. Brian Chalmers, also an orthopedic surgeon, adds “OrthAlign navigation gives me the control and confidence to set individualized alignment targets for different patients to optimize their soft tissue balance and outcomes.”

The handheld navigation technology is currently being used in hospitals and surgical facilities across the country.

In November of 2021 the company launched Lantern®, its newest technology, which builds upon the clinical success of OrthAlign; it has since become the company’s flagship product. It provides orthopedic surgeons with a state-of-the-art device for improving outcomes of total and partial knee replacement surgery.

Timko says he is excited to reach this milestone with HSS, which is consistently ranked Number 1 in orthopedics nationwide by U.S. News & World Report and worldwide by Newsweek, and has facilities in New York, New Jersey, Connecticut, and Florida.

He looks forward to more milestones in the future. “We are committed to making empowering technologies accessible to all. We believe the future is bright.”

OrthAlign, Inc., is a privately held U.S.-based medical device company that provides orthopedic surgeons with advanced precision computer-assisted technologies designed to deliver healthier and more pain-free lifestyles to joint replacement patients.

Driven by the belief that everyone deserves exceptional healthcare, we are committed to making empowering technologies accessible to all.

SourceOrthAlign
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy